Pipelines

(Image: Getty/BrianAJackson)

Hired and Retired: The knock-on effect

By Ben Hargreaves & Maggie Lynch

BMS’ capture of Celgene caught much attention, due to the size and scale of the acqusition, but rival companies have taken the chance to snap up employees that have left after the deal.

(Image: Getty/Zerbor)

GSK’s shingles vaccine approved in China

By Maggie Lynch

GSK is investing in ‘significant’ capacity expansion to support production of its shingles vaccine, which has been approved in China after clinical trials demonstrated 90% efficacy.

(Image: Getty/Hakinmhan)

Roche suffers third delay on Spark deal

By Ben Hargreaves

Roche’s acquisition of Spark was announced at the start of the year but closing the deal has proved difficult after a third delay incurred to give the FTC extra review time.

(Image: Getty/Milkos)

BIO-Europe Spring

Finding treatment solutions where there are none

By Ben Hargreaves

The industry focuses investments where there is the highest potential returns, but one panel at BIO-Europe Spring suggested multiple partners could boost outcomes in underserved therapeutic areas.

Follow us

Webinars